July 2011

Applications are invited on plain paper for the posts of Senior Research Fellow, Junior Research Fellow, and Project Attendant in the DBT-funded project entitled "Evaluation of the potential of probiotics (Lactobacillus SPP.) for the prevention and treatment of intestinal and vaginal parasitic infections" under Dr. Rakesh Sehgal, Professor, Department of Parasitology, PGIMER, Chandigarh-160012.

Celon Laboratories Limited is a fully integrated Pharmaceutical company a leader in development and marketing of specialty injectable products. Using in-house Research and Development capabilities, together with operational flexibility manufacturing and regulatory expertise, Celon is able to take a wide variety of products from laboratory to the market.

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Shreya Group origins go back to Moscow, Russia, where Shreya Corporation, the parent company, was established in 1995. Once a one-man trading company, Shreya is today the third largest Marketing & Distribution Company in Russia. Shreya Group has interests in both pharmaceutical and biopharmaceutical products in key therapeutic segments.

Tablets India Limited (TIL) is one of the leading manufacturers of various types of Pharmaceutical and nutraceutical formulations. The vital therapeutic range includes nutritional supplements, haematinics, hepatoprotectives, novel antipyretic, a unique G.I. Lavage preparation, Anti-Ulcerant, Osteoporotic Formula, Respiratory Medicine, etc.

Aurobindo Pharma has identified international operations, catering to over 100 countries, as a major engine of growth and expanding global network of marketing and manufacturing operations across countries like China, Brazil, Japan, Netherlands, South Africa, Thailand, UK, USA, Russia, Netherlands and many more which will further expand its international reach.